The product of the LAG-3 gene is a cell surface protein with significant homology to CD4. It has been suggested that it can serve as a functional equivalent of CD4 and account for the MHC class ll-restricted responses which persist in CD4-deficient mice. To test this hypothesis, we have created CD4/LAG-3 double-deficient mice by successive homologous recombinations in embryonic stem cells. These animals turn out to be indistinguishable from CD4 single-deficient mice in their lymphocyte populations and responses that are controlled by MHC class II molecules. LAG-3 thus does not explain class ll-restricted lymphocyte selection and function in the absence of CD4, strengthening the idea that these phenomena can occur independently of co-receptor signalling.
Introduction
Expression of the CD4 glycoprotein on a subset of T cells is highly correlated with recognition of antigens in the context of class II molecules of the MHC (1) . Several lines of evidence point to a critical role for CD4 as a co-receptor in class ll-mediated events. It plays a central role in positive selection of class ll-restricted T cells in the thymus (2) (3) (4) and is also important, although not indispensable, in class ll-mediated activation events in peripheral lymphoid organs and in T helper cell interactions with B cells (2) . There was some surprise, then, at results on CD4-deficient mice created by homologous recombination in embryonic stem (ES) cells (5, 6) . These animals had a sizeable population of double-negative (DN) CD4-CD8-TCRap + T cells, actually larger than that of wild-type animals. This population was dependent on MHC class II molecules and was responsible for the significant class ll-restricted T cell activity present in the mutant mice: proliferative response, help-dependent antibody production against virus or protein antigens and IFN-Y-mediated clearance of Leishmania infection (5, 6) .
What permits these class ll-restricted, yet CD4-independent, cells to arise and function? Two possibilities were proposed. First, these cells might express receptors with relatively high affinity for their ligand, allowing CD4-independent selection and function. CD4-independent T cell activation had been reported previously and attributed to high-affinity receptors (7); positive selection in the absence of CD4 could be accounted for in this fashion by invoking a stochastic model of T cell development, but is not compatible with a strict instructional model. The alternative interpretation was that another molecule complemented the function of the absent CD4, a redundancy with some precedent in gene knockout experiments.
The LAG-3 molecule (8,9) was proposed as a CD4 substitute (5, 6) . LAG-3 is a transmembrane glycoprotein which belongs to the Ig superfamily. LAG-3 and CD4 have a similar structure, with four Ig-like extracellular domains, and show significant similarity in amino acid sequence (8, 9) . The two genes map very close to each other in the human and mouse genomes, and have a highly resemblant intron-exon structure (8; T. Miyazaki era/., in preparation). Furthermore, Baixeras etal. provided evidence that human LAG-3, like CD4, might engage in low-affinity interactions with MHC class II molecules (9) . Thus, LAG-3 made an appealing candidate for complementing CD4 and explaining the partial phenotype of the CD4-knockout mice (5, 6) . We decided to explore this possibility by creating CD4/LAG-3 double-mutant mice.
Methods

Mice
We have described elsewhere mice carrying a knockout mutation of the LAG-3 gene (10). These mice derive from clone KE6 of ES cells, in which the LAG-3 gene was disrupted by recombination, leading to the insertion of a neomycin resistance cassette in lieu of exons 1-3 ( Fig. 1 A) . The mutation (12) . Wavy lines denote plasmid sequences (pBluescript). The mutated gene resulting from the homologous recombination event is schematized on the bottom line. The Sac\-Bgl\\ probe used for Southern blot analysis is shown, as are the 6.9 and 5.9 kb Sac\ fragments which hybridize to this probe, in wild-type and mutant genomic DNA respectively. Restriction enzymes: B, BamHI; C, C/al; G, Bgl\\; H, H/ndlll; K, Kpnl; P, Pstt; R, EcoRI; S, Sad; X, Xho\. (D) Southern Blot analysis of the CD4 allele. DNA was prepared from ES cell clones after electroporation of the construct shown in (C, middle line), digested with Sacl and probed with 0.9 kb Sac\-Bgl\\ fragment (C). The 6.9 kb wildtype band was replaced by a 5.9 kb mutant band in one of the six clones depicted here.
can be identified with the probe shown in Fig. 1 (A), as depicted in Fig. 1(B) . This mutation was kept on a mixed 129XB6 background. CD4-knockout mice (11) were a kind gift from D. Littman and were kept on a mixed 129xB6 background. This line was used in balanced crosses with the LAG-3/CD4 double mutation to provide the CD4 o/o LAG-3
mice used as CD4~LAG-3 + controls in the experiments. Mice were maintained in a clean conventional facility, following EEC guidelines.
Disruption of CD4 gene
To construct the CD4 targeting vector carrying the hygromycin-resistant gene (Hyg r ) fragment, we used the CD4 targeting vector previously constructed by Killeen et al. (11) and modified it by replacing the neomycin resistance gene by a Hyg r fragment. Briefly, a 0.6 kb Kpnl-EcoRI fragment, including the neomycin resistance gene and part of the CD4 exon 5, was excised from plasmid pCD4K7/2BTK and replaced by a 1.2 kb Cla\-Bgl\\ fragment from plasmid pHA58 (12) which contains the Hyg r coding region driven by the PGK promoter. The resulting constructs are schematized in Fig. 1(C, middle line) . ES cells (2x10 7 ) from KE6 clone, in which one allele of the LAG-3 gene had been already disrupted by homologous recombination (see above), were transfected by electroporation of 15 ug Ssp\ linearized CD4 targeting vector in 500 uJ of ES culture medium at 400 V/125 nF. After electroporation, cells were seeded on 10 cm gelatinized dishes in standard ES culture medium: DMEM (high glucose) supplemented with 1 mM sodium pyruvate, 0.4 ng/ml gentamycin, 15% FCS, 1000 U/ml LIF and 0-1 mM |3-mercaptoethanol. The source of LIF was culture supernatant of COS cells transfected with LIF expression plasmid pCiO-GR DIA/LIF (13) . Selection with 150 ng/ml hygromycin was imposed after 48 h. Surviving colonies were transferred into 48-well gelatinized plates after 10 days, at which time selection was removed. After expanding each colony, screening for homologous recombination was performed by Southern blot analysis after a Sacl digest, probed with the 0.9 kb Sac\-BgM fragment (Fig. 1C) . The identification of one such homologous recombination event is depicted in Fig. 1(D) .
Four targeted ES clones were injected into 3.5-day-old C57BL/6 blastocysts as described (14) . Male chimeric mice were mated to C57BL/6 females. The CD4 and LAG-3 mutations were transmitted and co-segregated in the progeny from one line, indicating that two mutations had taken place on the same chromosome. Animals carrying this chromosome were intercrossed to produce homozygous null mice. Screening of mice for the CD4 mutation was achieved by PCR (using primers AGCTTCGATGTAGGAGGGCGT and AACCCGCTC-GTCTGGCTAAGA, which amplify a 290 bp fragment of the Hyg r gene) and for the LAG-3 mutation by Southern blot (Fig. 1B) .
Antibodies and flow cytometry
Thymus or spleen cells were stained with saturating levels of mAb and analysed using a ELITE flow cytometer as described (15) .
T cell priming assay in vivo
Mice were immunized in the rear footpads with 50 ng chicken ovalbumin (OVA) emulsified in complete Freund's adjuvant (CFA). After 10 days, popliteal draining lymph node cells were harvested and challenged in culture with varying doses of OVA. Proliferation was assessed by incorporation of [ 3 H]thymidine in the last 16 h of a 4 day culture period.
T-dependent antibody production in vivo
Mice were immunized with 50 jig keyhole limpet haemocyanin (KLH) in CFA (i.p.) and boosted 21 days later with 10 ng KLH in PBS (i.p.). Seven days after the boost, sera were collected and the anti-KLH antibody evaluated by ELISA with an antiIgG second-step reagent (Jackson Immunoresearch, West Grove, PA) as described (16) .
Results and discussion
To explore the function of murine LAG-3, we had previously generated mutant mice lacking this gene; LAG-3 expression was abolished in these mice but they exhibited, as judged from multiple analyses, normal MHC class ll-restricted immune functions (10) .
To determine whether LAG-3 was indeed substituting for CD4 in the CD4-deficient animals, we decided to create LAG-3/CD4 double-knockout mice. Because the genes are very closely linked, the usual approach of crossing the single mutants to generate a double mutant was not feasible. Therefore, we elected to mutate the CD4 gene in ES cells in which the LAG-3 gene had already been disrupted by homologous recombination. The hygromycin resistance gene was inserted within a segment of the cloned CD4 gene, in the same configuration as used by Killeen era/. (11) in their initial mutagenesis. This plasmid DNA was then electroporated into the ES clone KE6 (10) , in which the LAG-3 gene had already been disrupted by recombinational insertion of the neomycin resistance gene. Four of the resulting 130 hygromycin-resistant colonies were found to have undergone the desired homologous recombination event at the CD4 locus. Two of the four ES clones gave rise to germline transmission; in one case, the CD4 and LAG-3 mutations did not cosegregate in progeny, indicating that the two mutations had taken place on alternate chromosomes; in the progeny derived from the last clone, however, the mutations co-segregated. Doubly homozygous LAG 0/0 CD4 0/0 mice were generated by intercrossing this line. The CD4 single-deficient mice used in the experiments described below were obtained by crossing the double-mutant line with the original CD4 single-mutant line (11), thus yielding LAG +/0 CD4 o/0 mice, as well as phenotypically wild-type controls.
We first quantitated, by three-color flow cytometry, the size of the DN TCRocp + population, observed to be expanded in previous studies of CD4 single-deficient mice. As expected and illustrated in Fig. 2(A) , we did find a marked increase in the population of TCRa(J + CD4"CD8" cells in CD4 o/o animals. Such an increase was also detected in LAG o/o CD4 o/o animals. Measurements from several such experiments are tabulated in Fig. 2(B) : it is clear that the prevalence of TCRaP + CD4" CD8~ cells is not affected by the absence of LAG-3, both in relative proportion of cells (in lymph node) and in absolute numbers (in spleen).
These observations were extended to the thymi of the same set of mice. As shown in Fig. 3 , there was an increased population of DN TCRaP" We then evaluated the capacity of the mutant mice to mount MHC class ll-restricted responses, using an assay known to give completely negative results in class ll-deficient mice (14) but positive results in CD4~ animals, albeit at reduced levels (4-6): mice were challenged with KLH to explore their capacity to mount an antibody response to a T-dependent antigen (Fig. 4B) . Here again, a reduced but very significant response Of course, the possibility remains that another, hitherto unidentified, molecule has a function redundant to that of CD4. Yet, by removing from contention the only plausible candidate proposed to date, we have rendered more likely the alternative interpretation, that the increased population of DN cells with class ll-restricted function results from coreceptor-independent thymic selection. These represent a substantial number of cells, -20% of the CD4 + cells found in a normal mouse. The existence of such a mode of selection cannot readily be accounted for by instructional models of positive selection (17) (18) (19) , which posit that the initial commitment to the CD4 lineage requires that the cell undergoing selection must sense the class of MHC molecule that engages its TCR, most readily through co-receptor coengagement. It is, in contrast, fully compatible with stochastic views (15, (20) (21) (22) : selection into the CD4 lineage in the absence of co-engagement and signalling by the CD4 molecule would correspond to those cells whose receptor has enough intrinsic affinity for MHC targets to achieve selection without co-receptor participation. The observations are also compatible with the '50/50' models which have been recently proposed (23, 24) 
